RECONSTITUTION OF WILD-TYPE P53 EXPRESSION TRIGGERS APOPTOSIS IN A P53-NEGATIVE V-MYC RETROVIRUS-INDUCED T-CELL LYMPHOMA LINE

被引:0
|
作者
WANG, YS
RAMQVIST, T
SZEKELY, L
AXELSON, H
KLEIN, G
WIMAN, KG
机构
来源
CELL GROWTH & DIFFERENTIATION | 1993年 / 4卷 / 06期
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Inactivation or mutation of the p53 tumor suppressor gene has been observed in a wide variety of human and murine tumors. We have found that a v-myc retrovirus (J3)-induced T-cell lymphoma line (J3D) has lost one of its p53 alleles, whereas the other has become inactivated due to the insertion of a Moloney murine leukemia provirus in intron 4 with an opposite transcriptional orientation. No p53 protein could be detected by immunoprecipitation with monoclonal anti-p53 antibodies. We have transfected this line with the temperature-sensitive murine Val135 construct that is expressed as mutant p53 at 37-degree-C and largely wild-type p53 at 32-degree-C. There was no difference in the number of viable cells among the p53 transfectants, the parental cells, and neomycin vector-transfected control cells at 37-degrees-C. Following a temperature shift to 32-degrees-C, the p53 transfectants rapidly lost viability, and 95-100% of the cells were dead by 3 days, whereas the control cells remained unaffected. Examination of DNA isolated from p53-transfected cells grown at 32-degrees-C revealed nucleosomal fragmentation, indicating cell death by apoptosis. It is suggested that apoptosis is triggered by contradictory signaling. Constitutively expressed v-myc can stimulate cell proliferation, whereas expression of wild-type p53 in cells that have lost endogenous p53 expression in the course of their neoplastic development may suppress growth.
引用
收藏
页码:467 / 473
页数:7
相关论文
共 50 条
  • [21] INDUCTION OF APOPTOSIS BY WILD-TYPE P53 IN A HUMAN COLON TUMOR-DERIVED CELL-LINE
    SHAW, P
    BOVEY, R
    TARDY, S
    SAHLI, R
    SORDAT, B
    COSTA, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) : 4495 - 4499
  • [22] Induction of differentiation by wild-type p53 gene in a human glioma cell line
    Kokunai, T
    Kawamura, A
    Tamaki, N
    JOURNAL OF NEURO-ONCOLOGY, 1997, 32 (02) : 125 - 133
  • [23] Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer Immunotherapy
    Li, Demin
    Bentley, Carol
    Anderson, Amanda
    Wiblin, Sarah
    Cleary, Kirstie L. S.
    Koustoulidou, Sofia
    Hassanali, Tasneem
    Yates, Jenna
    Greig, Jenny
    Nordkamp, Marloes Olde
    Trenevska, Iva
    Ternette, Nicola
    Kessler, Benedikt M.
    Cornelissen, Bart
    Cragg, Mark S.
    Banham, Alison H.
    CANCER RESEARCH, 2017, 77 (10) : 2699 - 2711
  • [24] Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53
    Forrester, K
    Ambs, S
    Lupold, SE
    Kapust, RB
    Spillare, EA
    Weinberg, WC
    FelleyBosco, E
    Wang, XW
    Geller, DA
    Tzeng, E
    Billiar, TR
    Harris, CC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (06) : 2442 - 2447
  • [25] UV-C induced apoptosis in p53 wild-type, Apaf-1 and p53 knockout mouse embryonic fibroblasts
    Tomicic, MT
    Christmann, M
    Kaina, B
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 111 - 111
  • [26] Boswellic acids induced apoptosis in human glioblastoma T98G (p53 mutant) and U87MG (p53 wild-type) cell lines
    Das, Arabinda
    Banik, Naren
    Ray, Swapan
    CANCER RESEARCH, 2009, 69
  • [27] Differentiation induced by RB expression and apoptosis induced by p53 expression in an osteosarcoma cell line
    Keizou Ookawa
    Shigeki Tsuchida
    Jun-ichi Adachi
    Jun Yokota
    Oncogene, 1997, 14 : 1389 - 1396
  • [28] Differentiation induced by RB expression and apoptosis induced by p53 expression in an osteosarcoma cell line
    Ookawa, K
    Tsuchida, S
    Adachi, J
    Yokota, J
    ONCOGENE, 1997, 14 (12) : 1389 - 1396
  • [29] Therapeutic usefulness of wild-type p53 gene introduction in a p53-null anaplastic thyroid carcinoma cell line
    Narimatsu, M
    Nagayama, Y
    Akino, K
    Yasuda, M
    Yamamoto, T
    Yang, TT
    Ohtsuru, A
    Namba, H
    Yamashita, S
    Ayabe, H
    Niwa, M
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (10): : 3668 - 3672
  • [30] EVIDENCE THAT C-MYC MEDIATED APOPTOSIS DOES NOT REQUIRE WILD-TYPE P53 DURING LYMPHOMAGENESIS
    HSU, B
    MARIN, MC
    ELNAGGAR, AK
    STEPHENS, LC
    BRISBAY, S
    MCDONNELL, TJ
    ONCOGENE, 1995, 11 (01) : 175 - 179